Skip to NavigationSkip to content

pharma jobs

Pharma companies ‘among happiest places to work’

Amgen scientist
Amgen was ranked the 'happiest' pharma company to work for in America

Five pharmaceutical companies have placed in a top 50 of the happiest companies in America listing, based on reviews by employees, with two leading drugmakers making the top three. 

Amgen, Novartis, Johnson & Johnson, MSD and Pfizer all ranked in online career community CareerBliss’ sixth annual 50 Happiest Companies in America awards list. The survey is compiled using thousands of independent company reviews submitted to the CareerBliss site by employees between 2014 and 2015. 

The ex-CEO's Job Blog - part 1

Published on 03/09/12 at 12:00am

I have seen a lot in my healthcare career. Been round the block more than twice, as they say.

I have been fired, promoted and downsized (OK, made redundant). I have experienced abject failure and thankfully, some degree of success. I have helped a few on their way up and also ‘encouraged’ one or two to find less demanding roles in other industries.

R&D jobs in emerging markets - leaders wanted

Published on 29/09/11 at 12:40pm
Peter Mansell
Shanghai
Shanghai, where virtually all of pharma’s biggest players have established research centres in the last 5-10 years

The globalisation of pharmaceutical research and development is creating a wave of job opportunities in emerging markets such as India and China.

Pharma investment began with simple ‘offshoring’, which exploits lower costs in back office functions, but now emerging markets are seen as a vital part of international R&D networks and lucrative markets in their own right.

This has seen some major shifts in R&D investment from Europe and the US and into emerging markets, with full scale drug discovery and early stage development now being done in these regions.

Pfizer to retain 350 jobs at Sandwich

Pfizer R&D Sandwich, Kent

Pfizer has made the surprise decision to retain 350 jobs at its research and development site in Sandwich, Kent, providing a welcome reprieve for some employees.

Pfizer announced its exit from the Sandwich site in February, and said virtually all of the 2,400 jobs at the site would be lost.

NicOx to halve HQ workforce

French pharmaceutical company NicOx is to halve the workforce at its Sophia Antipolis headquarters and is considering restructuring its Italian research centre near Milan.

The company has set aside 4.7 million euros to pay for its restructuring plan, which follow the FDA’s rejection of its anti-inflammatory drug naproxcinod in July.

Biogen set to axe 650 jobs and focus on neurology

Biogen Idec is set to cut hundreds of jobs and refocus its R&D in an effort to cut costs by $300 million.

The US biotech firm will cut around 13% of its workforce, with the reductions mainly coming from axing its cardiovascular R&D and one of its larger sites in San Diego.

Its eastern Massachusetts sites in Waltham and Wellesley will be consolidated in Cambridge and Weston to further streamline their workforce.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches